Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Stemcell United Ltd. ( (AU:BP8) ) has provided an announcement.
BPH Global Ltd, a company with a focus on Traditional Chinese Medicine-based natural formulations, has entered into an Exclusive Dealing Agreement with Denmark-based scientist Jo-an Refugio to evaluate a proprietary ginseng-based formulation aimed at enhancing male vitality and wellbeing. This agreement grants BPH Global a six-month exclusivity period to conduct due diligence and product testing, with the potential to acquire intellectual property rights and engage Jo-an as an R&D consultant. The formulation is part of BPH Global’s broader R&D initiative, exploring both natural over-the-counter products and evidence-based, clinically tested products.
More about Stemcell United Ltd.
Current Market Cap: A$2.6M
Learn more about BP8 stock on TipRanks’ Stock Analysis page.